CPS Capital Investor Update Note: Speculative Buy
CPS Capital CEO, Jason Peterson and major shareholder of Cynata Therapeutics Ltd (“CYP”), provided an update on the company to investors, since his last review in May 2016.
Mr Peterson provided the following information:
Since my last update on CYP, it has been pleasing to see that the company has been meeting its milestones and delivering to the market in line with its business strategy. Some exciting news has come out of this company which seems to be reflected in the upward price trend of the chart below, particularly in the last month.